|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Severe Caner Pain | |||||
| 2 | Interventions listed in this trial | ||||
| Oxycodone Hydrochloride | |||||
| 3 | Additional drug interventions recognized in this trial | ||||
| Oxycodone | |||||
| 4 | More general drug interventions related to this trial | ||||
| Analgesics | |||||
| Analgesics, Opioid | |||||
| Central Nervous System Agents | |||||
| Central Nervous System Depressants | |||||
| Narcotics | |||||
| Peripheral Nervous System Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Sensory System Agents | |||||
| Therapeutic Uses | |||||
| 5 | Sponsors listed in this trial | ||||
| Mundipharma Research Limited | |||||